IKONISYS

ikonisys-logo

Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to helping physicians and researchers realize the promise of rare cell detection to give patients the best chance of managing their disease.

#SimilarOrganizations #People #Financial #Website #More

IKONISYS

Industry:
Biotechnology Health Care Health Diagnostics

Founded:
1999-01-01

Address:
New Haven, Connecticut, United States

Country:
United States

Website Url:
http://www.ikonisys.com

Total Employee:
51+

Status:
Active

Contact:
2037760795

Total Funding:
48.71 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Apache Microsoft Exchange Online Amazon Office 365 Mail


Similar Organizations

human-longevity-logo

Human Longevity

Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.

Current Employees Featured

michael-kilpatrick_image

Michael Kilpatrick
Michael Kilpatrick Chief Scientific Officer @ Ikonisys
Chief Scientific Officer
2017-01-01

michael-kilpatrick_image

Michael Kilpatrick
Michael Kilpatrick Vice-President for Biology @ Ikonisys
Vice-President for Biology
2001-01-01

Founder


michael-kilpatrick_image

Michael Kilpatrick

Stock Details


Company's stock symbol is EPA:ALIKO

Investors List

saint-simeon-marketing-and-investments_image

Saint Simeon Marketing and Investments

Saint Simeon Marketing and Investments investment in Series E - Ikonisys

palisade-capital-management_image

Palisade Capital Management

Palisade Capital Management investment in Series E - Ikonisys

lakeview-capital-management_image

Lakeview Capital Management

Lakeview Capital Management investment in Series E - Ikonisys

new-science-ventures_image

New Science Ventures

New Science Ventures investment in Series E - Ikonisys

goldman-sachs_image

Goldman Sachs

Goldman Sachs investment in Series E - Ikonisys

wgi-group_image

WGI Group

WGI Group investment in Series D - Ikonisys

lakeview-capital-management_image

Lakeview Capital Management

Lakeview Capital Management investment in Series D - Ikonisys

trevi-health-ventures_image

Trevi Health Ventures

Trevi Health Ventures investment in Series D - Ikonisys

new-science-ventures_image

New Science Ventures

New Science Ventures investment in Series D - Ikonisys

Official Site Inspections

http://www.ikonisys.com

  • Host name: gunn.dnshigh.com
  • IP address: 93.95.216.122
  • Location: Rome Italy
  • Latitude: 41.8904
  • Longitude: 12.5124
  • Timezone: Europe/Rome
  • Postal: 00155

Loading ...

More informations about "Ikonisys"

Ikonisys โ€“ Finding the cells that matter

With a relentless commitment to innovation, precision, and reliability, Ikonisys continuously sets the industry standard, empowering laboratories worldwide with unparalleled tools and โ€ฆSee details»

Company โ€“ Ikonisys

Ikonisys is a leading cell-based diagnostics company that markets the proprietary Ikoniscope® Digital Microscope, engineered to provide highly accurate and reliable detection of rare cells. ... a research organization specializing in โ€ฆSee details»

Ikonisys - Crunchbase Company Profile & Funding

Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and โ€ฆSee details»

Careers โ€“ Ikonisys

We encourage teamwork and collaboration across all levels of the organization. By working together, we achieve greater results and foster a sense of belonging and camaraderie. ...See details»

Ikonisys Company Profile 2024: Valuation, Investors, Acquisition ...

Ikonisys General Information Description. Ikonisys SA is specialized in the design, manufacture and marketing of medical diagnostic equipment. The company offers cell diagnostic products โ€ฆSee details»

Ikonisys - LinkedIn

Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection. Through a unique combination of technology and science, Ikonisys is dedicated to ...See details»

Ikonisys - Funding, Financials, Valuation & Investors - Crunchbase

Ikonisys is registered under the ticker EPA:ALIKO . Their stock opened with โ‚ฌ5.75 in its Jul 19, 2021 IPO. Ikonisys is funded by 8 investors. Cambria Equity Partners and Saint Simeon โ€ฆSee details»

Ikonisys, Inc. Company Profile | New Haven, CT | Competitors ...

/ Ikonisys, Inc. Ikonisys, Inc. Website. Get a D&B Hoovers Free Trial. Overview Company Description: Ikonisys is developing diagnostic tests for oncology and prenatal applications. The โ€ฆSee details»

Ikonisys - Finding the Cells that matter

Feb 2022 I Management Presentation I CONFIDENTIAL โ€“Ikonisys Company Presentation February 2022. Not to be distributed, directly or indirectly, in the United States, Canada, โ€ฆSee details»

Ikonisys - Org Chart, Teams, Culture & Jobs - The Org

View Ikonisys' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»

Ikonisys - Overview, News & Similar companies | ZoomInfo.com

Dec 28, 2023 Who is Ikonisys. Ikonisys SA is a cell-based diagnostics company based in Paris (France), New Haven (Connecticut, USA) and Milan (Italy) specialized in the early an d โ€ฆSee details»

Ikonisys Company Profile - Office Locations, Competitors ... - Craft

Ikonisys is a cell-based diagnostics company. It develops Ikoniscope digital microscope used for the diagnosis of a variety of cancers; oncoFISH diagnostic applications are built for the โ€ฆSee details»

Contact โ€“ Ikonisys

New Haven, Paris, Milan, Florence. Feel free to contact any of our offices, and come to visit our premises. We warmly invite you to visit any of our offices to experience our world-class โ€ฆSee details»

Ikonisys - Crunchbase

Ikonisys, SomaLogic, and Human Longevity are part of the diagnostic and healthcare technology sector. Ikonisys focuses on non-invasive disease detection, while SomaLogic specializes in โ€ฆSee details»

The Ikonisys Group Unveils its New Vision and Strategy Under the โ€ฆ

Dec 4, 2024 Ikonisys Alessandro Mauri CFO [email protected] NewCap Louis-Victor Delouvrier/Aurélie Manavarere Investor Relations [email protected] Tel.: +33 (0)1 44 71 โ€ฆSee details»

Investors - Ikonisys

Ikonisys stands out due to our proprietary hardware and software solutions, advanced imaging systems, and a commitment to continuous innovation. Our technology delivers the fastest and โ€ฆSee details»

Ikonisys - Contacts, Employees, Board Members, Advisors & Alumni

Ikonisys is transforming diagnostic medicine by enabling early, accurate and non-invasive disease detection.See details»

The Ikonisys Group Unveils its New Vision and Strategy Under the โ€ฆ

PARIS, December 04, 2024--Regulatory News: ALIKO SCIENTIFIC (Ikonisys SA) (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers โ€ฆSee details»

Ikonisys - Find the cells that matter

Ikonisys announces announces the launch of the Ikoniscope20max, a new configuration of the recently-launched Ikoniscope20, that includes a high-volume slide loader. The โ€ฆSee details»

Cancer Diagnostic Solutions โ€“ Ikonisys

The collaboration between Hospitex International and Ikonisys within the same corporate group has resulted in the creation of powerful synergies that benefit the field of medical diagnostics. โ€ฆSee details»

linkstock.net © 2022. All rights reserved